Aligos Therapeutics (ALGS) Capital Leases (2019 - 2025)
Aligos Therapeutics' Capital Leases was $122,000 in Q3 2025, down 35.1% from $188,000 a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Aligos Therapeutics (ALGS) Capital Leases (2019 - 2025) Analysis & Trends
From Q4 2019 onward, Aligos Therapeutics has reported Capital Leases for 22 quarters.
- Capital Leases shows a five-year compound annual growth rate of -7.3% (FY2019 to FY2024).
- In earlier years, Capital Leases was $231,000 in FY2023 (+0.4%), $230,000 in FY2022 (-11.9%), $261,000 in FY2021 (+100.8%) and $130,000 in FY2020 (-27.0%).
- Quarterly Capital Leases has moved between $53,000 (Q3 2021) and $261,000 (Q4 2021) over five years.
- Compared with a year earlier, Capital Leases has declined for four straight quarters, with an average decline of 20.0% over the last eight quarters.
- The best year-over-year quarter for Capital Leases over five years was Q3 2022 (growth of 228.3%); the worst was Q3 2021 (a decline of 59.2%).
- Per Business Quant data, ALGS's Capital Leases in the three quarters before Q3 2025 was $122,000 (Q2 2025), $122,000 (Q1 2025) and $122,000 (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Aligos Therapeutics | 52.83 Mn | -275.57 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 122,000.00 |
| Jun 30, 2025 | 122,000.00 |
| Mar 31, 2025 | 122,000.00 |
| Dec 31, 2024 | 122,000.00 |
| Sep 30, 2024 | 188,000.00 |
| Jun 30, 2024 | 203,000.00 |
| Mar 31, 2024 | 217,000.00 |
| Dec 31, 2023 | 231,000.00 |
| Sep 30, 2023 | 188,000.00 |
| Jun 30, 2023 | 203,000.00 |
| Mar 31, 2023 | 205,000.00 |
| Dec 31, 2022 | 230,000.00 |
| Sep 30, 2022 | 174,000.00 |
| Jun 30, 2022 | 201,000.00 |
| Mar 31, 2022 | 231,000.00 |
| Dec 31, 2021 | 261,000.00 |
| Sep 30, 2021 | 53,000.00 |
| Jun 30, 2021 | 130,000.00 |
| Mar 31, 2021 | 130,000.00 |
| Dec 31, 2020 | 130,000.00 |
API Access
Aligos Therapeutics Capital Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-leases&ticker=ALGS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-leases", "ticker": "ALGS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-leases&ticker=ALGS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();